Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px
All >

News > Northern Europe

Please find below news about Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden and the UK as well as about organisations from these countries.

Total search results: 4945 | Ordered by Date (descending)
1 2 3 ... 48 49 50  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Oncopeptides AB. (12/2/19). "Press Release: Oncopeptides Appoints Joseph Horvat as President North America". Stockholm. 2019-12-02
Owkin. (12/2/19). "Press Release: Owkin Teams up with NVIDIA and King's College London to Deliver AI to Hospitals While Protecting Patient Data With Federated Learning". Paris & New York. 2019-12-02
Lunac Therapeutics Ltd.. (12/2/19). "Press Release: Lunac Therapeutics Led Project Awarded £3.14 Million under Innovate UK Biomedical Catalyst Programme, to Develop Next-generation Anticoagulant". Leeds. 2019-12-02
Novo Holdings A/S. (11/26/19). "Press Release: Novo Seeds Expands Company Formation Activities at BiOrigin with Seasoned Entrepreneurs". Copenhagen. 2019-11-26
GeNeuro S.A.. (11/25/19). "Press Release: GeNeuro and the Karolinska Institutet/Academic Specialist Center of Stockholm Agree to Launch a New Clinical Study of Temelimab in Multiple Sclerosis". Geneva. 2019-11-25
Azeria Therapeutics Ltd.. (11/21/19). "Press Release: Azeria Therapeutics Announces £32.0 million Series B Financing". London. 2019-11-21
GHO Capital Partners LLP. (11/20/19). "Press Release: GHO Capital Raises €975m in Largest Ever European Healthcare Fund". London. 2019-11-20
Sangamo Therapeutics, Inc.. (11/19/19). "Press Release: Sangamo Announces UK Authorization of a Phase 1/2 Clinical Trial Evaluating the CAR-Treg Cell Therapy TX200 for Kidney Transplantation". Brisbane, CA. 2019-11-19
Zelluna Immunotherapy AS. (11/19/19). "Press Release: Zelluna Immunotherapy and Glycostem Therapeutics Announce Partnership to Develop Allogeneic TCR-NK Therapies". Oslo & Oss. 2019-11-19
Novo Nordisk A/S. (11/18/19). "Press Release: Dicerna and Novo Nordisk Enter Agreement to Discover and Develop RNAi Therapies for Liver-related Cardio-metabolic Diseases". Lexington, MA & Bagsvaerd. 2019-11-18
Okra Technologies Ltd.. (11/15/19). "Press Release: Okra Becomes a Veeva Technology Partner". Cambridge. 2019-11-15
Lunac Therapeutics Ltd.. (11/14/19). "Press Release: Lunac Therapeutics Spun out to Develop Next Generation Anticoagulants, and Announces Series A Funding Round". Leeds. 2019-11-14
Fujifilm Corporation. (11/14/19). "Press Release: Fujifilm Announces Expansion of its Biopharmaceutical Contract Development and Manufacturing Business". Tokyo. 2019-11-14
Avacta Group plc. (11/13/19). "Press Release: LG Chem Life Sciences Expands Partnership with Avacta". 2019-11-13
Turbine Kft.. (11/13/19). "Press Release: Turbine Secures €3 Million Seed Fund to Expand the Potential of Simulation-first Drug discovery". London & Budapest. 2019-11-13
Innate Pharma S.A.. (11/13/19). "Press Release: Innate Pharma Third Quarter 2019 Report". 2019-11-13
Bavarian Nordic A/S. (11/13/19). "Press Release: Bavarian Nordic Announces Appointment of Jean-Christophe May as Executive Vice President and Chief Commercial Officer". Copenhagen. 2019-11-13
Expedeon AG. (11/11/19). "Press Release: Expedeon AG Signs EUR 120 Million Deal with Abcam for the Sale of Its immunology and Proteomics Business". Heidelberg & Cambridge. 2019-11-11
Owlstone Medical Ltd.. (11/7/19). "Press Release: Owlstone Medical Enters Partnership with Thermo Fisher Scientific to Advance Early Disease Detection Using Non-invasive Breath Biopsy". Cambridge. 2019-11-07
Waters Corporation. (11/7/19). "Press Release: World’s First Cyclic IMS Mass Spectrometer Installed at Aston University". Milford, MA. 2019-11-07
AstraZeneca plc. (11/6/19). "Press Release: AstraZeneca Announces Three Large-scale Initiatives in China to Advance Global Medicine Research and Development". 2019-11-06
Greenough. (11/6/19). "Press Release: Agencies Align Life Science/Healthcare Expertise to Offer Integrated Marketing Services on Both Sides of the Pond". Watertown, MA. 2019-11-06
Artios Pharma Ltd.. (11/6/19). "Press Release: Artios Pharma, MD Anderson and ShangPharma Announce In-licensing Agreement for DNA Damage Response Inhibitor". Cambridge, New York, NY, Houston, TX & South San Franicsco, CA. 2019-11-06
Rentschler Biopharma SE. (11/6/19). "Press Release: Rentschler Biopharma Kicks off Expansion at U.S. Facility in the Boston Biotech Hub". Laupheim & Milford, MA. 2019-11-06
Ervaxx Ltd.. (11/6/19). "Press Release: Ervaxx Launches to Pioneer the Use of Dark Antigens for the Development of Off-the-Shelf Cancer Vaccines and T-cell Receptor-based Immunotherapies". London. 2019-11-06
Zelluna Immunotherapy AS. (11/4/19). "Press Release: Zelluna Immunotherapy Appoints Dr Bent Jakobsen, a Pioneer of TCR Therapeutics, to the Board of Directors". Oslo. 2019-11-04
Bicycle Therapeutics plc. (10/31/19). "Press Release: Bicycle Therapeutics Announces Appointment of Veronica Jordan, Ph.D., to Board of Directors". Cambridge & Boston, MA. 2019-10-31
Mesa Laboratories, Inc.. (10/31/19). "Press Release: Mesa Labs Acquires Gyros Protein Technologies". Lakewood, CO. 2019-10-31
AstraZeneca plc. (10/30/19). "Press Release: AstraZeneca Divests Rights to Seroquel and Seroquel XR in Europe and Russia". 2019-10-30
Disc Medicine. (10/29/19). "Press Release: Disc Medicine Completes $50 Million Series A Financing led by Novo Holdings A/S to Advance New Therapies Addressing Ineffective Red Blood Cell Production". Cambridge, MA. 2019-10-29
Bicycle Therapeutics plc. (10/29/19). "Press Release: Bicycle Therapeutics Announces Appointment of Nigel Crockett, Ph.D., as Chief Business Officer". Cambridge & Boston, MA. 2019-10-29
Parc Cientific de Barcelona (BCP, Barcelona Science Park Foundation). (10/28/19). "Press Release: Molomics Opens an Investment Round to Accelerate an Innovative Project against Parkinson’s". Planegg & Mechelen. 2019-10-28
AstraZeneca plc. (10/24/19). "Press Release: Year-to-Date and Q3 2019 Results". 2019-10-24
H. Lundbeck A/S. (10/22/19). "Press Release: Lundbeck Completes the Acquisition of Alder BioPharmaceuticals – a Company Committed to Transforming Migraine Treatment and Prevention". Valby. 2019-10-22
Bicycle Therapeutics plc. (10/22/19). "Press Release: Bicycle Therapeutics Expands Neuroscience Collaborations to include Oxford University’s Oxford Drug Discovery Institute". Cambridge & Boston, MA. 2019-10-22
Arnold & Porter LLP. (10/22/19). "Press Release: Life Sciences Lawyer and Former EMA Legal Adviser Alexander Roussanov Joins Arnold & Porter in Brussels". Brussels. 2019-10-22
Zealand Pharma A/S. (10/22/19). "Press Release: Zealand Pharma Expands Its Peptide Platform with Acquisition of Encycle Therapeutics". Copenhagen. 2019-10-22
Cancer Research UK. (10/21/19). "Press Release: International Alliance Sets Bold Research Ambition to Detect the (almost) Undetectable". 2019-10-21
Bavarian Nordic A/S. (10/21/19). "Press Release: Bavarian Nordic Announces a Transformative Acquisition of Two Established Commercial Vaccines from GlaxoSmithKline". Copenhagen. 2019-10-21
CRISPR Therapeutics AG. (10/21/19). "Press Release: CRISPR Therapeutics and Bayer Announce an Update on Casebia Therapeutics". Leverkusen, Zug & Cambridge, MA. 2019-10-21
ReViral Ltd.. (10/21/19). "Press Release: ReViral Announces Appointment of Alan Musso as Chief Financial Officer". London. 2019-10-21
BC Platforms. (10/17/19). "Press Release: BC Platforms Partners with Blueprint Genetics to Provide Center of Excellence for Data Driven Testing Services in Rare Diseases". Zürich & Boston, MA. 2019-10-17
Amarna Therapeutics B.V.. (10/16/19). "Press Release: Amarna Therapeutics Raises €10 Million to Progress Lead Development Candidate into Clinical Trials and Appoints a New Supervisory Board". Leiden. 2019-10-16
Healx Ltd.. (10/16/19). "Press Release: Healx Secures $56m in Series B Financing, Launches Global Accelerator Programme for Rare Diseases". Cambridge. 2019-10-16
GammaDelta Therapeutics Ltd.. (10/16/19). "Press Release: Adaptate Biotherapeutics Formed to Develop Antibody-based Therapies that Modulate Gamma Delta T-cells". London. 2019-10-16
Cell Mogrify Ltd.. (10/14/19). "Press Release: Mogrify Raises Additional $16 Million to Advance Its Mission to Transform the Development of Life-saving Cell Therapies". Cambridge. 2019-10-14
Evotec SE. (10/10/19). "Press Release: Just-Evotec Biologics and Biocon Biologics Sign Licensing Deal for a Biosimilar Asset". Hamburg, Seattle, WA & Bengaluru. 2019-10-10
Bayer AG. (10/10/19). "Press Release: Bayer Launches LifeHub UK Focused on Artificial Intelligence to Optimize Data-driven Drug discovery and Disease Diagnosis". Leverkusen & Reading. 2019-10-10
Bluebird Bio, Inc.. (10/9/19). "Press Release: Bluebird Bio and Novo Nordisk Enter into Research Agreement to Develop in vivo Genome Editing Candidates for Haemophilia and Other Severe Genetic Diseases". Cambridge, MA & Bagsvaerd. 2019-10-09
N-Side S.A.. (10/9/19). "Press Release: N-Side Welcomes Wade Wirta as US Managing Director". Louvain-la-Neuve. 2019-10-09
Agilent Technologies Inc.. (10/9/19). "Press Release: Agilent Opens State-of-the-Art Spectroscopy Site in the UK". Santa Clara, CA. 2019-10-09
Cyclica Inc.. (10/8/19). "Press Release: To Build Stronger Partnerships Globally, Cyclica Appoints Long Time Pharma R&D Leader Vern De Biasi as VP, Global Head of Strategic Partnerships". Toronto. 2019-10-08
GlaxoSmithKline plc. (10/8/19). "Press Release: GSK and Lyell Immunopharma Join Forces to Develop the Next Generation of Cancer Cell Therapies". London & San Francisco, CA. 2019-10-08
Vivoryon Therapeutics AG. (10/8/19). "Press Release: Vivoryon Therapeutics AG Launches Rights Offering to Fund its Phase 2b Clinical Development Program in Alzheimer’s Disease with Strong Commitments [Not for US, et al.]". Halle (Saale). 2019-10-08
4D Pharma plc. (10/8/19). "Press Release: 4D Pharma Collaborates with MSD to Develop Live Biotherapeutics for Vaccines". 2019-10-08
Solentim Ltd.. (10/8/19). "Press Release: Mark Stockdale Joins Solentim in New »Amalgamator of Business and Biology« Position". Bournemouth. 2019-10-08
MiroBio Ltd.. (10/7/19). "Press Release: MiroBio Launches with £27m ($34m) Series A from Leading Life Sciences Investors". Oxford. 2019-10-07
LeadXPro AG. (10/7/19). "Press Release: LeadXPro and Lundbeck enter Strategic Partnership on Membrane Protein Structure Research". Villigen. 2019-10-07
Adaptimmune Ltd.. (10/5/19). "Press Release: United States Orphan Drug Designation for Treatment of Soft Tissue Sarcomas Granted to SPEAR T-cells Targeting MAGE-A4". Philadeliphia, PA & Oxfordshire. 2019-10-05
Genomenon, Inc.. (10/2/19). "Press Release: Congenica Partners with Genomenon to Integrate Mastermind into Congenica Clinical Platform". Ann Arbor, MI. 2019-10-02
N-Side S.A.. (10/1/19). "Press Release: AstraZeneca Selects N-Side Suite for Clinical Trials to Optimize and Monitor Clinical Trial Supply Chain". Louvain-la-Neuve. 2019-10-01
Adaptimmune Ltd.. (10/1/19). "Press Release: Adaptimmune Announces Appointment of Michael Garone as Interim Chief Financial Officer". Philadeliphia, PA & Oxfordshire. 2019-10-01
Solentim Ltd.. (10/1/19). "Press Release: Dr Mark Truesdale Joins Solentim as New Chief Marketing Officer". Bournemouth. 2019-10-01
Arix Bioscience plc. (9/30/19). "Press Release: Arix Co-leads EUR 20 Million Series A Investment Round in STipe Therapeutics". London. 2019-09-30
Arctoris Ltd.. (9/30/19). "Press Release: Arctoris Ltd Secures Seed Funding of £3.2 Million to Advance Novel Drug Discovery Platform Powered by Robotics". London. 2019-09-30
Adaptimmune Ltd.. (9/30/19). "Press Release: Clear Benefit for Patients with Synovial Sarcoma Demonstrated in Updated Data from Ongoing Phase 1 Trial with ADP-A2M4 Presented at ESMO". Philadeliphia, PA & Oxfordshire. 2019-09-30
Consilium Strategic Communications Ltd.. (9/26/19). "Press Release: Consilium Strategic Communications Expands International Senior Team with Four New Appointments". London & Boston, MA. 2019-09-26
Zealand Pharma A/S. (9/24/19). "Press Release: Zealand Pharma Achieves Primary and All Key Secondary Endpoints in Pediatric Phase 3 Trial with Dasiglucagon for Severe Hypoglycemia". Copenhagen. 2019-09-24
MolPort. (9/24/19). "Press Release: MolPort Expansion Enables more Efficient Compound and Reagent Sourcing in the USA". Riga. 2019-09-24
Innate Pharma S.A.. (9/23/19). "Press Release: Innate Pharma Announces Clinical Data Presentations on IPH5401 and Monalizumab at ESMO 2019". Marseille. 2019-09-23
Oncimmune Holdings plc. (9/20/19). "Press Release: €8.5m Credit Facility Secured. Funding to Accelerate the Further Commercialisation of Oncimmune’s Lead Products and Services". 2019-09-20
H. Lundbeck A/S. (9/20/19). "Press Release: Lundbeck and Takeda Announce Ministry of Health, Labour and Welfare (MHLW) Approval of Trintellix in Japan". 2019-09-20
PredictImmune Ltd.. (9/19/19). "Press Release: PredictImmune Announces New ‘Framework Agreement’ with Cambridge Enterprise". Cambridge. 2019-09-19
Divide & Conquer. (9/18/19). "Press Release: Divide & Conquer, Developing New Class of Cancer Therapeutics to Disrupt Cell-to-Cell Communication, Emerges from Stealth as New Paper by Co-Founder is Published in Nature". Cambridge. 2019-09-18
Amra Medical AB. (9/17/19). "Press Release: Amra Medical Welcomes Jonas Lindqvist to the Team as Director of Operations as It Strengthens Its Delivery Capabilities in Clinical Trials". Linköping. 2019-09-17
Procarta Biosystems Ltd.. (9/17/19). "Press Release: Procarta Receives CARB-X Award of up to $9.2 million". Stevenage. 2019-09-17
BenevolentAI Ltd.. (9/17/19). "Press Release: BenevolentAI Announces $90 Million Investment from Temasek". London. 2019-09-17
H. Lundbeck A/S. (9/16/19). "Press Release: Lundbeck to Acquire Alder BioPharmaceuticals – a Company Committed to Transforming Migraine Treatment and Prevention – in a Transaction Valued at up to USD 1.95 Billion Net of Cash". Valby & Bothell, WA. 2019-09-16
PPF Group N.V.. (9/16/19). "Press Release: PPF Expands Its Investment in the Healthcare Sector through Acquisition of Significant Stake in T Cell Therapy Company Autolus Therapeutics". 2019-09-16
UCL Technology Fund. (9/16/19). "Press Release: Echopoint Raises £2.8m to Address the ‘Grey Zone’ of Heart Disease treatment". 2019-09-16
Lytix Biopharma AS. (9/12/19). "Press Release: Lytix Biopharma AS Appoints Øystein Rekdal as the new CEO". 2019-09-12
Genedata AG. (9/11/19). "Press Release: Orion Pharmaceuticals Implements Genedata Biologics to Support New Large-Molecule R&D Initiative". Basel. 2019-09-11
o2h Discovery. (9/11/19). "Press Release: Cedilla Therapeutics and o2h Discovery Are Pleased to Announce Multi FTE Expansion to Their Synthetic Chemistry Collaboration". Cambridge & Cambridge, MA. 2019-09-11
UK Biobank. (9/11/19). "Press Release: UK Biobank Leads the Way in Genetics Research to Tackle Chronic Diseases". 2019-09-11
Amra Medical AB. (9/10/19). "Press Release: Amra Announces Strategic Partnership with Japanese Leading Imaging CRO, Micron, Inc., to Support Clinical Trials in Japan". Linköping. 2019-09-10
BioAscent Discovery Ltd.. (9/9/19). "Press Release: BioAscent Expands into US Market, Appoints Julian Abery to Spearhead Growth". Newhouse. 2019-09-09
4BIO Capital (4BIO Ventures Management Ltd.). (9/9/19). "Press Release: 4BIO Capital Raises $50 million in First Close of New Advanced Therapies Fund". London & Boston, MA. 2019-09-09
Cell Mogrify Ltd.. (9/9/19). "Press Release: Mogrify Appoints Dr. Jane Osbourn, OBE as Chair". Cambridge. 2019-09-09
Genmab A/S. (9/9/19). "Press Release: Genmab and Tempus Enter into Strategic Collaboration Agreement". Copenhagen. 2019-09-09
Lightcast Discovery Ltd.. (9/9/19). "Press Release: Lightcast Discovery Raises £1.3m in Seed Financing to Expand Pilot Studies". Cambridge. 2019-09-09
Theragnostics Ltd.. (9/5/19). "Press Release: Theragnostics Signs Agreement with AstraZeneca". London. 2019-09-05
Owlstone Medical Ltd.. (9/5/19). "Press Release: Owlstone Medical Announces Advancements in Breath Biopsy Platform Including Launch of Next Generation ReCIVA Breath Sampler and CASPER Portable Air Supply". Cambridge. 2019-09-05
Sigrid Therapeutics AB. (9/5/19). "Press Release: Stockholm-based Technology Startup Sigrid Therapeutics, Developing SiPore15 – a Breakthrough Device to Lower Blood Sugar Levels, Closes Oversubscribed Round of $1.6m, Bringing Total Pre-launch Funding to 2019-09-05
Boehringer Ingelheim. (9/3/19). "Press Release: Boehringer Ingelheim and Zealand Pharma Advance Dual-Acting GLP-1/Glucagon Agonist BI 456906 to Phase 2 Clinical Testing in Obesity/Diabetes". Ingelheim & Copenhagen. 2019-09-03
Achilles Therapeutics. (9/3/19). "Press Release: Achilles Therapeutics Raises £100 Million in Oversubscribed Series B Financing". Stevenage. 2019-09-03
Bruker Corporation. (9/2/19). "Press Release: Bruker Launches Highest Resolution Large-Format Bio-AFM System". Münster. 2019-09-02
RhoVac AB. (9/2/19). "Press Release: RhoVac Optimizes the Structure of the Management Team and Appoints Anders Månsson as New CEO". 2019-09-02
Orbit Discovery Ltd.. (8/30/19). "Press Release: Mario Polywka Joins Orbit Discovery’s Board of Directors". Oxford. 2019-08-30
BioCity Group Ltd.. (8/29/19). "Press Release: BioCity Invests in Early-stage Precision Medicine Biotech Kinomica". Cheshire. 2019-08-29
Ascendis Pharma A/S. (8/28/19). "Press Release: Ascendis Pharma A/S Reports Second Quarter 2019 Financial Results". Copenhagen. 2019-08-28
1 2 3 ... 48 49 50  next pagenext page



Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px

» top